ENTXEntera Bio Ltd.Healthcare · Biotechnologyas of 2026-09-16
Horizon

Issued 2026-09-16 at $2.96 · now $2.96 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, ENTX has typically landed between $2.17 and $4.36 — a range of −26.6% to +47.2% from the issuance price $2.96.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

2,041 overlapping 1 month windows · 2018-06-28 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($2.96) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where ENTX has typically landed a month from the 2026-09-16 close of $2.96 — the range is history, not a prediction.

$2.17worst · -26.6%$4.36best · +47.2%
  • now $2.96 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $2.83 (-4.4%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $2.41–$3.25
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $2.17–$4.36
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 2,041 windows spanning 2018-06-28 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2021-03-17−48.8%−48.8%+0.0%
2020-02-18−48.1%−48.1%+3.9%
2018-11-23−43.4%−43.4%+3.6%
3 best
2021-02-11+222.0%−25.3%+222.0%
2021-02-09+201.0%−29.5%+201.0%
2021-02-10+182.5%−28.0%+207.4%

2,041 overlapping windows · 2018-06-28 – 2026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~9 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
75%
+16.8%
n=8
Feb
50%
+7.9%
n=8
Mar
50%
+19.0%
n=8
Apr
63%
+0.5%
n=8
May
38%
−4.6%
n=8
Jun
50%
+8.0%
n=8
Jul
33%
+6.3%
n=9
Aug
11%
−10.1%
n=9
Sep
44%
−0.8%
n=9
Oct
13%
−1.7%
n=8
Nov
25%
−6.9%
n=8
Dec
25%
−9.1%
n=8

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$3$12026-03-09: 1 insider purchase, $26K — Germano Geno J2026-03-05: 1 insider purchase, $12K — Ellis Sean2026-02-10: 4 insider purchases, $82K — Germano Geno J, Taitel Haya …2026-02-09: 1 insider purchase, $22K — Ellis Sean2025-12-29: 1 insider purchase, $20K — Toledano Miranda Jayne2025-12: 1 open-market purchase, $20K2026-02: 5 open-market purchases, $104K2026-03: 2 open-market purchases, $38K↑ buys↓ salesdirector Germano Geno J — Purchase on 2026-03-09, filed 2 days after the tradedirector Ellis Sean — Purchase on 2026-03-05, filed 4 days after the tradedirector Germano Geno J — Purchase on 2026-02-10, filed 1 day after the tradedirector Germano Geno J — Purchase on 2026-02-10, filed 1 day after the tradedirector Taitel Haya — Purchase on 2026-02-10, filed 1 day after the tradedirector Taitel Haya — Purchase on 2026-02-10, filed 1 day after the tradedirector Ellis Sean — Purchase on 2026-02-09, filed 2 days after the tradedirector Toledano Miranda Jayne — Purchase on 2025-12-29, filed 1 day after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-03-09Germano Geno JdirectorPurchase20,000 @ $1.30$26K+100.0% of holding−12.0%+100.5%40,000Form 4 · filed 2 days after the trade
2026-03-05Ellis SeandirectorPurchase10,000 @ $1.23$12K+5.6% of holding−0.2%+130.3%188,098Form 4 · filed 4 days after the trade
2026-02-10Germano Geno JdirectorPurchase20,000 @ $1.49$30Kownership Δ n/a−5.2%+84.9%—Form 4 · filed 1 day after the trade
2026-02-10Germano Geno JdirectorPurchase20,000 @ $1.49$30Kownership Δ n/a−5.2%+84.9%—Form 4 · filed 1 day after the trade
2026-02-10Taitel HayadirectorPurchase7,500 @ $1.48$11Kownership Δ n/a−5.2%+84.9%—Form 4 · filed 1 day after the trade
2026-02-10Taitel HayadirectorPurchase7,500 @ $1.48$11Kownership Δ n/a−5.2%+84.9%—Form 4 · filed 1 day after the trade
2026-02-09Ellis SeandirectorPurchase18,000 @ $1.24$22K+11.2% of holding+7.0%+98.6%178,098Form 4 · filed 2 days after the trade
2025-12-29Toledano Miranda JaynedirectorPurchase11,000 @ $1.81$20K+2.6% of holding−19.8%−15.1%426,575Form 4 · filed 1 day after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

48 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-08-07Ellis SeandirectorAward / grant20,034208,132Form 4
2026-08-07Ellis SeandirectorAward / grant40,00040,000Form 4
2026-08-07Germano Geno JdirectorAward / grant25,01465,014Form 4
2026-08-07Germano Geno JdirectorAward / grant50,00050,000Form 4
2026-08-07Burshtein GregoryofficerAward / grant180,000180,000Form 4
2026-08-07Germano Geno JdirectorAward / grant43,01443,014Form 4
2026-08-07Toledano Miranda JaynedirectorAward / grant500,000500,000Form 4
2026-08-07Toledano Miranda JaynedirectorAward / grant200,000200,000Form 4
2026-08-07Galitzer HillelofficerAward / grant200,000200,000Form 4
2026-08-07Yaacov-Garbeli DanaofficerAward / grant140,000140,000Form 4
2026-08-07Taitel HayadirectorAward / grant20,790119,269Form 4
2026-08-07Malca YonatandirectorAward / grant22,815100,231Form 4
2026-07-14Toledano Miranda JaynedirectorAward / grant347,567774,142Form 4
2026-07-14Toledano Miranda JaynedirectorAward / grant72,993847,135Form 4
2026-05-07Galitzer HillelofficerAward / grant72,993163,566Form 4
2026-05-07Burshtein GregoryofficerAward / grant87,591189,033Form 4
2026-05-07Yaacov-Garbeli DanaofficerAward / grant58,394171,441Form 4
2026-01-01Malca YonatandirectorAward / grant30,15777,416Form 4
2026-01-01OSTROV GERALD MdirectorAward / grant28,72175,657Form 4
2026-01-01OSTROV GERALD MdirectorAward / grant33,50533,505Form 4
2026-01-01Taitel HayadirectorAward / grant26,32990,979Form 4
2026-01-01Taitel HayadirectorAward / grant33,50533,505Form 4
2026-01-01Malca YonatandirectorAward / grant33,50533,505Form 4
2026-01-01LIEBERMAN GERALD MdirectorAward / grant38,294338,454Form 4
2026-01-01LIEBERMAN GERALD MdirectorAward / grant33,50533,505Form 4
2026-01-01Ellis SeandirectorAward / grant25,371160,098Form 4
2026-01-01Ellis SeandirectorAward / grant33,50533,505Form 4
2025-07-16Burshtein GregoryofficerAward / grant200,000200,000Form 4
2025-07-16Toledano Miranda JaynedirectorAward / grant136,842371,715Form 4
2025-07-16Toledano Miranda JaynedirectorAward / grant43,860415,575Form 4
2025-07-16Toledano Miranda JaynedirectorAward / grant500,000500,000Form 4
2025-07-16Yaacov-Garbeli DanaofficerAward / grant26,316113,047Form 4
2025-07-16Yaacov-Garbeli DanaofficerAward / grant130,000130,000Form 4
2025-07-16Burshtein GregoryofficerAward / grant26,316101,442Form 4
2025-04-28Galitzer HillelofficerAward / grant26,31690,573Form 4
2025-04-28Galitzer HillelofficerAward / grant100,000100,000Form 4
2025-04-01LIEBERMAN GERALD MdirectorOption exercise23,952300,160Form 4
2025-04-01LIEBERMAN GERALD MdirectorOption exercise23,95228,509Form 4
2025-01-15LIEBERMAN GERALD MdirectorAward / grant10,717276,208Form 4
2025-01-15Ellis SeandirectorAward / grant7,100134,727Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.